One in every 10 people worldwide is impacted by a rare genetic disease but about 50% of them remain undiagnosed despite rapid ...

AlleyWatch sat down with Nucleus CEO and Founder Kian Sadeghi to learn more about the business, its future plans, and recent ...

When we can play any part in supporting other families, it’s a tragic gift that allows us to continue to parent Havi.” For ...

The company, founded by 25-year-old Kian Sadeghi, announced a $14 million Series A, bringing its total funding to about $32 million.

AI-driven genomics startups leverage technology to analyze genetic data, predict predispositions, and offer personalized ...

A new test developed in the UK can accurately predict whether high-risk patients will develop bowel cancer, also known as ...

On December 17, 2024, the Department of Health & Human Services, Office of Inspector General (HHS-OIG) issued its second favorable advisory ...

Approximately 160 tests are set to be conducted annually by the NHS to screen for 'high-risk' genetic variants.

“At AEON Clinic, we bridge the gap between science and health. Genomic insights allow us to address health risks at their ...

The NHS has launched a new genetic blood test to improve the safety of kidney donations from people of Black African and ...

Hundreds of potential kidney donors of Black African and Black Caribbean heritage in the UK can now get a simple blood test to help reduce the risk of kidney failure.